Jianhao Xu

ORCID: 0000-0002-2064-4597
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • MicroRNA in disease regulation
  • Mycobacterium research and diagnosis
  • Gastric Cancer Management and Outcomes
  • Schizophrenia research and treatment
  • RNA modifications and cancer
  • Cancer Mechanisms and Therapy
  • Circular RNAs in diseases
  • Ovarian cancer diagnosis and treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Ureteral procedures and complications
  • Colorectal Cancer Treatments and Studies
  • Renal and related cancers
  • Emergency and Acute Care Studies
  • Maternal and Perinatal Health Interventions
  • Cell Image Analysis Techniques
  • Recommender Systems and Techniques
  • Inflammatory Biomarkers in Disease Prognosis
  • Ion Channels and Receptors
  • Maternal and fetal healthcare
  • Family Caregiving in Mental Illness
  • Alkaloids: synthesis and pharmacology
  • Security and Verification in Computing

First People's Hospital of Kunshan
2019-2024

Jiangsu University
2019-2024

Yangzhou University
2022

Soochow University
2018-2019

Second Affiliated Hospital of Soochow University
2018-2019

Nanjing University of Science and Technology
2019

Huazhong University of Science and Technology
2018

Hubei Cancer Hospital
2018

Nanning Normal University
2016

Hubei University of Technology
2015

This study aimed to investigate the aberrant expression of hsa_circ_0002874 in non-small cell lung cancer (NSCLC) and elucidate associated molecular mechanisms that influence apoptosis induce paclitaxel (PTX) resistance.Inhibitors were used downregulate circRNA or miRNA expression. pCDNA plasmid transfection mimics upregulate Dual-luciferase reporter assays conducted evaluate interactions between miR1273f MDM2. Xenograft tumor models assess effect on growth. NSCLC tissues matched...

10.18632/aging.202521 article EN cc-by Aging 2021-02-17

Objective This study aimed to explore the relationship between CD276 and clear cell renal carcinoma (ccRCC) assess diagnostic value of in ccRCC. Methods Expression levels ccRCC para-cancer tissues were compared analyzed retrospectively using data obtained from TCGA GEO databases. The clinical was prospectively. Immunohistochemistry RT-PCR analyses used analyze expression at mRNA protein levels. These 70 patients with Next, ELISA peripheral blood samples 72 healthy individuals, facilitating...

10.1177/10732748241250181 article EN cc-by-nc Cancer Control 2024-01-01

With the emergence of hardware-assisted processor tracing, execution traces can be logged with lower runtime overhead and integrated into core dump. In comparison an ordinary dump, such a new post-crash artifact provides software developers security analysts more clues to program crash. However, existing works only rely on resolved information, which leads limitation in data flow recovery within long traces. this work, we propose POMP++, automated tool facilitate analysis artifacts. More...

10.1109/tse.2019.2939528 article EN publisher-specific-oa IEEE Transactions on Software Engineering 2019-01-01

To assess CD276 expression and explore its relationship with the clinicopathological characteristics prognosis of patients bladder cancer.

10.3389/fonc.2024.1445526 article EN cc-by Frontiers in Oncology 2024-09-10

Radiotherapy-related pain is a common adverse reaction with high incidence among cancer patients undergoing radiotherapy and remarkably reduces the quality of life. However, mechanisms ionizing radiation-induced are largely unknown. In this study, mice were treated 20 Gy X-ray to establish model. evoked prolonged mechanical, heat, cold allodynia in mice. Transient receptor potential vanilloid 1 transient ankyrin significantly upregulated lumbar dorsal root ganglion. The mechanical heat could...

10.1177/1744806919849201 article EN cc-by-nc Molecular Pain 2019-01-01

To evaluate the efficacy and safety of liposome-paclitaxel (L-PTX)/L-PTX plus S-1 in advanced gastric cancer patients with poor performance status (PS).We performed this retrospective study on 17 PS [rated as ≥2 based Eastern Cooperative Oncology Group (ECOG) scale] who underwent following chemotherapy regimen: (I) L-PTX single-agent: 60-80 mg/m2 given days 1 8, a 21-day cycle; (II) timed sequential (TS) 8. S-1, 40-60 twice day 1-14, cycle. Initially, some could not tolerate 2-drug...

10.21037/tcr.2019.08.17 article EN Translational Cancer Research 2019-09-01

Intravascular leiomyoma (IVL) is usually defined as a histologically benign that originates in uterine fibroid or the intrauterine vein wall and grows expands intravenously. We report case which pelvic IVL was detected early discuss diagnosis of best treatment for this tumor.

10.1089/whr.2023.0091 article EN cc-by Women s Health Reports 2024-03-01

<title>Abstract</title> <bold>Background:</bold> The traditional TNM staging system for colorectal cancer (CRC) is limited by the biological characteristics of tumors and their high heterogeneity. This study proposes a pathological signature (PScrc) based on digital pathology technology, aimed at assessing its prognostic value in overall survival (OS) disease-free (DFS) through analysis various features hematoxylin eosin (HE)-stained slides. <bold>Methods: </bold>A retrospective cohort was...

10.21203/rs.3.rs-5425912/v1 preprint EN cc-by Research Square (Research Square) 2024-12-17

Abstract Background : MicroRNAs (miRNAs) are involved in the initiation and development of cancer, participate drug resistance. Paclitaxel (PTX) is first-line chemotherapy for advanced non-small cell lung cancer (NSCLC). The abnormal miRNA expression NSCLC its association with resistance remains largely unknown. study aimed to investigate aberrant miR-221-3p elucidate molecular mechanisms relation PTX Methods Quantitative polymerase chain reaction (qPCR) was used examine messenger RNA (mRNA)...

10.21203/rs.3.rs-36548/v1 preprint EN cc-by Research Square (Research Square) 2020-06-22
Coming Soon ...